Biogen and Neomorph have partnered to discover and develop molecular glue degrad...
Pharmaceutical management expert Kenneth Getz shares insights on broader trends ...
Amidst a share value slump and executive turmoil, Pfizer reported a robust quart...
The company has axed 80% of its staff and is considering a wind-down after the o...
As the Horizon acquisition reaps its benefits, Amgen is now turning eyes to its ...
Reeves' budget promised investment for innovation and R&D with a view to "harnes...
Experts predict that physicians may favour emerging biosimilar versions of Stela...
AbbVie has entered a definitive agreement to acquire all outstanding equity of A...
The Pharmaceutical Automation and Digitalisation Congress (AUTOMA+) 2024 is a st...
As the retail drug pharmacy space undergoes significant change, new formats and ...
UPFs have become a staple of many diets worldwide, but overconsumption is contri...
The SIRT6 activator’s sex-specific effects shed light on the different genetic p...
Organon has completed the acquisition of Dermavant Sciences, a subsidiary of Roi...
The registrational trial is expected to support the approval for Bavarian’s mpox...
At the Outsourcing in Clinical Trials Conference, US government personnel advise...
